Clinical Trials Browser

Phase 3 × Liver Neoplasms × contrast agent BR1 × Clear all

NCT00829413 2018-08-03

SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization

Phase 3 Completed

353 enrolled 16 charts

Gastrointestinal

Liver Neoplasms